Caleb Bell
Private Equity Investor at CTIC Capital LLC
Profile
Caleb B.
Bell was the founder of Bell Biosystems, Inc. (founded in 2009) and Digital Movement, Inc. (founded in 1999), where he held the titles of Director and CEO respectively.
Currently, Dr. Bell is the Managing Director at CTIC Capital LLC (since 2022) and a Venture Partner at Beyond Next Ventures, Inc. (since 2019).
He is also an Advisor at Myoridge KK (since 2018), Metcela, Inc. (since 2019), and GlycoMira Therapeutics, Inc. (since 2022).
Previously, Dr. Bell served as a Director at IVIVA Medical, Inc. (2021), a member of the Institute Board of Directors at California Life Sciences Association (2014-2020), a Director at Elevian, Inc. (2021), a Partner at Prime Movers Lab LLC (2020-2021), a Senior Advisor at Arcline Investment Management LP (2019), and an Advisor at Argonaut Genomics, Inc. (2020-2022).
Dr. Bell obtained a doctorate degree from Stanford University in 2011, an undergraduate degree from The Pennsylvania State University, and an MBA from Stanford Graduate School of Business in 2009.
Caleb Bell active positions
Companies | Position | Start |
---|---|---|
CTIC Capital LLC | Private Equity Investor | 2021-12-31 |
Beyond Next Ventures, Inc.
Beyond Next Ventures, Inc. Investment ManagersFinance Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo. | Private Equity Investor | 2019-02-28 |
GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew. | Consultant / Advisor | 2022-01-31 |
Metcela, Inc.
Metcela, Inc. Miscellaneous Commercial ServicesCommercial Services Metcela, Inc. provides therapies for heart failure treatment. The company was founded by Takahiro Iwamiya and Kenichi Nogami on March 09, 2016 and is headquartered in Kawasaki, Japan. | Consultant / Advisor | 2019-05-31 |
Myoridge KK
Myoridge KK BiotechnologyHealth Technology Myoridge KK is a company based in Kyoto, Japan that specializes in selling cell products and developing support services for cell culture. The Japanese company also offers development support services for materials, operating methods, and equipment for all stages of the process. The company was founded in 2016 by Naohiro Makita, Shinichi Sueda. | Consultant / Advisor | 2018-08-31 |
Former positions of Caleb Bell
Companies | Position | End |
---|---|---|
Argonaut Genomics, Inc. | Consultant / Advisor | 2022-01-31 |
Iviva Medical, Inc.
Iviva Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Iviva Medical, Inc. develops autologous tissue to serve kidney diseases. The company was founded by Harald C Ott and is headquartered in Beverly, MA. | Director/Board Member | 2021-11-30 |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Director/Board Member | 2021-10-31 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Director/Board Member | 2020-11-30 |
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Caleb Bell
The Pennsylvania State University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 13 |
---|---|
Bell Biosystems, Inc.
Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
CTIC Capital LLC | |
Iviva Medical, Inc.
Iviva Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Iviva Medical, Inc. develops autologous tissue to serve kidney diseases. The company was founded by Harald C Ott and is headquartered in Beverly, MA. | Commercial Services |
Beyond Next Ventures, Inc.
Beyond Next Ventures, Inc. Investment ManagersFinance Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo. | Finance |
GlycoMira Therapeutics, Inc.
GlycoMira Therapeutics, Inc. BiotechnologyHealth Technology GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company based in Salt Lake City, UT. The private company is dedicated to improving the standard of care and outcomes for patients with cancer and other inflammatory diseases. GlycoMira is developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. The company's lead drug candidate, GM-1111, has demonstrated potential to address unmet needs in solid tumor treatment and supportive care. The CEO of the company is William P. Tew. | Health Technology |
Metcela, Inc.
Metcela, Inc. Miscellaneous Commercial ServicesCommercial Services Metcela, Inc. provides therapies for heart failure treatment. The company was founded by Takahiro Iwamiya and Kenichi Nogami on March 09, 2016 and is headquartered in Kawasaki, Japan. | Commercial Services |
Myoridge KK
Myoridge KK BiotechnologyHealth Technology Myoridge KK is a company based in Kyoto, Japan that specializes in selling cell products and developing support services for cell culture. The Japanese company also offers development support services for materials, operating methods, and equipment for all stages of the process. The company was founded in 2016 by Naohiro Makita, Shinichi Sueda. | Health Technology |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Commercial Services |
Arcline Investment Management LP
Arcline Investment Management LP Investment ManagersFinance Arcline Investment Management LP (Arcline Investment) is a private equity firm founded in 2018 by Rajeev Joseph Amara. The firm is headquartered in San Francisco, California. | Finance |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | Finance |
Argonaut Genomics, Inc. | |
Digital Movement, Inc. |
- Stock Market
- Insiders
- Caleb Bell